SEARCH

SEARCH BY CITATION

References

  • 1
    International Rhinosinusitis Advisory Board. Infectious rhinosinusitis in adults: classification, etiology and management. Ear Nose Throat J 1997;76:122.
  • 2
    Collins JG. Prevalence of selected chronic conditions: United States, 1990–1992. Vital Health Stat 1997;10:189.
  • 3
    Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004;114:155212.
  • 4
    Fokkens W, Lund V, Bachert C, Clement P, Helllings P, Holmstrom M et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy 2005;60:583601.
  • 5
    Ratjen F, Doring G. Cystic fibrosis. Lancet 2003;361:681689.
  • 6
    Schubert MS. Allergic fungal sinusitis. Otolaryngol Clin North Am 2004;37:301326.
  • 7
    Claeys S, Van Hoecke H, Holtappels G, Gevaert P, De Belder T, Verhasselt B et al. Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators. Clin Exp Allergy 2005;35:467472.
  • 8
    Hamilos DL, Leung DY, Huston DP, Kamil A, Wood R, Hamid Q. GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP). Clin Exp Allergy 1998;28:11451152.
  • 9
    Hamilos DL, Leung DY, Wood R, Cunningham L, Bean DK, Yasruel Z et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995;96:537544.
  • 10
    Bachert C, Wagenmann M, Hauser U, Rudack C. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997;99:837842.
  • 11
    Lee CH, Rhee CS, Min YG. Cytokine gene expression in nasal polyps. Ann Otol Rhinol Laryngol 1998;107:665670.
  • 12
    Min YG, Lee CH, Rhee CS, Kim KH, Kim CS, Koh YY et al. Inflammatory cytokine expression on nasal polyps developed in allergic and infectious rhinitis. Acta Otolaryngol 1997;117:302306.
  • 13
    Riechelmann H, Deutschle T, Rozsasi A, Keck T, Polzehl D, Burner H. Nasal biomarker profiles in acute and chronic rhinosinusitis. Clin Exp Allergy 2005;35:11861191.
  • 14
    Watelet JB, Bachert C, Claeys C, Van Cauwenberge P. Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy 2004;59:5460.
  • 15
    Bachert C, Wagenmann M, Rudack C, Hopken K, Hillebrandt M, Wang D et al. The role of cytokines in infectious sinusitis and nasal polyposis. Allergy 1998;53:213.
  • 16
    Lund VJ, Kennedy DW. Quantification for staging sinusitis. The Staging and Therapy Group. Ann Otol Rhinol Laryngol Suppl 1995;167:1721.
  • 17
    Gevaert P, Bachert C, Holtappels G, Novo CP, Van der Heyden J, Fransen L et al. Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis. Allergy 2003;58:371379.
  • 18
    Demetter P, De Vos M, Van Huysse JA, Baeten D, Ferdinande L, Peeters H et al. Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163. Ann Rheum Dis 2005;64:321324.
  • 19
    Lund VJ. Diagnosis and treatment of nasal polyps. BMJ 1995;311:14111414.
  • 20
    Deal RT, Kountakis SE. Significance of nasal polyps in chronic rhinosinusitis: symptoms and surgical outcomes. Laryngoscope 2004;114:19321935.
  • 21
    Kim JT, Kim CK, Koh YY. Serum levels of soluble interleukin-2 receptor at acute asthma exacerbation: relationship with severity of exacerbation and bronchodilator response. Int Arch Allergy Immunol 1998;117:263269.
  • 22
    Mathias C, Mick R, Grupp S, Duffy K, Harris F, Laport G et al. Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation. J Hematother Stem Cell Res 2000;9:393400.
  • 23
    Fleischer B. Superantigens. APMIS 1994;102:312.
  • 24
    Rott O, Mignon-Godefroy K, Fleischer B, Charreire J, Cash E. Superantigens induce primary T cell responses to soluble autoantigens by a non-V beta-specific mechanism of bystander activation. Cell Immunol 1995;161:158165.
  • 25
    Gevaert P, Holtappels G, Johansson SG, Cuvelier C, Cauwenberge P, Bachert C. Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy 2005;60:7179.
  • 26
    Bachert C, Gevaert P, Holtappels G, Johansson SG, Van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001;107:607614.
  • 27
    Van Zele T, Gevaert P, Watelet JB, Claeys G, Holtappels G, Claeys C et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004;114:981983.
  • 28
    Muhlebach MS, Stewart PW, Leigh MW, Noah TL. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 1999;160:186191.
  • 29
    Elias J. The relationship between asthma and COPD. Lessons from transgenic mice. Chest 2004;126:111S116S; discussion 59S–61S.
  • 30
    Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H et al. TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol 2004;172:834842.
  • 31
    Cerwenka A, Bevec D, Majdic O, Knapp W, Holter W. TGF-beta 1 is a potent inducer of human effector T cells. J Immunol 1994;153:43674377.
  • 32
    Vignola AM, Chanez P, Chiappara G, Merendino A, Zinnanti E, Bousquet J et al. Release of transforming growth factor-beta (TGF-beta) and fibronectin by alveolar macrophages in airway diseases. Clin Exp Immunol 1996;106:114119.
  • 33
    Watelet JB, Claeys C, Perez-Novo C, Gevaert P, Van Cauwenberge P, Bachert C. Transforming growth factor beta1 in nasal remodeling: differences between chronic rhinosinusitis and nasal polyposis. Am J Rhinol 2004;18:267272.
  • 34
    Alam R, Forsythe P, Stafford S, Fukuda Y. Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J Exp Med 1994;179:10411045.
  • 35
    Bachert C, Gevaert P, Holtappels G, Cuvelier C, Van Cauwenberge P. Nasal polyposis: from cytokines to growth. Am J Rhinol 2000;14:279290.
  • 36
    Sobol SE, Christodoulopoulos P, Manoukian JJ, Hauber HP, Frenkiel S, Desrosiers M et al. Cytokine profile of chronic sinusitis in patients with cystic fibrosis. Arch Otolaryngol Head Neck Surg 2002;128:12951298.
  • 37
    Kim JS, Hackley GH, Okamoto K, Rubin BK. Sputum processing for evaluation of inflammatory mediators. Pediatr Pulmonol 2001;32:152158.